1. Home
  2. TMCI vs CDXS Comparison

TMCI vs CDXS Comparison

Compare TMCI & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$1.84

Market Cap

144.0M

Sector

Health Care

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.21

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
CDXS
Founded
2014
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
144.0M
141.8M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
TMCI
CDXS
Price
$1.84
$1.21
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$4.21
N/A
AVG Volume (30 Days)
617.2K
1.2M
Earning Date
02-27-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$218,879,000.00
$52,932,000.00
Revenue This Year
$3.30
$15.64
Revenue Next Year
N/A
$5.23
P/E Ratio
N/A
N/A
Revenue Growth
7.90
N/A
52 Week Low
$1.86
$1.12
52 Week High
$10.30
$4.46

Technical Indicators

Market Signals
Indicator
TMCI
CDXS
Relative Strength Index (RSI) 28.79 36.19
Support Level $2.02 $1.12
Resistance Level $2.31 $1.28
Average True Range (ATR) 0.16 0.11
MACD -0.03 -0.01
Stochastic Oscillator 7.88 23.61

Price Performance

Historical Comparison
TMCI
CDXS

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: